Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 8, 2014, Pages 1305-1313

  Li, Xiao Shan ^a   Xu, Qing ^a   Fu, Xiang Yang ^a   Luo, Wei Sheng ^a  

^a GUILIN MEDICAL UNIVERSITY   (China)

Author keywords

Aggressiveness; Gastric cancer; Heat shock protein 22; Prognosis

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GELATINASE B; HEAT SHOCK PROTEIN 22; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CONTINUOUS INFUSION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STOMACH CANCER; TUMOR INVASION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAT-SHOCK PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN-SERINE-THREONINE KINASES; STOMACH NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904305583     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1698-z     Document Type: Article

References (23)

1. Al-Batran SE, Hartmann JT, Probst S et al (2008) Phase iii trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. J Clin Oncol 26:1435-1442
2. Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of her2-positive advanced gastric or gastro-oesophageal junction cancer (toga): a phase 3, open-label, randomised controlled trial. Lancet 376:687-697
3. Calderwood SK, Khaleque MA, Sawyer DB et al (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164-172 (Pubitemid 43361923)
4. Charpentier AH, Bednarek AK, Daniel RL et al (2000) Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60:5977-5983
5. Chu D, Zhang Z, Li Y et al (2011) Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer (Journal international du cancer) 129:887-895
6. Compare D, Rocco A, Nardone G (2010) Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 14:302-308
7. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
8. Dikken JL, van Sandick JW, Maurits Swellengrebel HA et al (2011) Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (critics). BMC Cancer 11:329
9. Edge SB, Compton CC (2010) The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471-1474
10. Gober MD, Wales SQ, Aurelian L (2005) Herpes simplex virus type 2 encodes a heat shock protein homologue with apoptosis regulatory functions. Front Biosci J Virtual Libr 10:2788-2803 (Pubitemid 40905275)
11. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
12. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150 (Pubitemid 46655601)
13. Kim HJ, Hwang NR, Lee KJ (2007) Heat shock responses for understanding diseases of protein denaturation. Mol Cells 23:123-131 (Pubitemid 46711672)
14. Modem S, Chinnakannu K, Bai U et al (2011) Hsp22 (hspb8/h11) knockdown induces sam68 expression and stimulates proliferation of glioblastoma cells. J Cell Physiol 226:2747-2751
15. Nelson AR, Fingleton B, Rothenberg ML et al (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149 (Pubitemid 30123793)
16. Smith CC, Yu YX, Kulka M et al (2000) A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine pk and is expressed in melanoma cells. J Biol Chem 275:25690-25699
17. Sun X, Fontaine JM, Rest JS et al (2004) Interaction of human HSP22 (HSPB8) with other small heat shock proteins. J Biol Chem 279:2394-2402 (Pubitemid 38114222)
18. Uversky VN, Oldfield CJ, Dunker AK (2005) Showing your ID: intrinsic disorder as an id for recognition, regulation and cell signaling. JMR 18:343-384 (Pubitemid 41341287)
19. Wadhwa R, Ryu J, Gao R et al (2010) Proproliferative functions of drosophila small mitochondrial heat shock protein 22 in human cells. J Biol Chem 285:3833-3839
20. Wang J, Cui S, Zhang X et al (2013) High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer. PLoS ONE 8:e62876
21. Wu AW, Xu GW, Wang HY et al (2007) Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev (2):CD005047
22. Yang C, Trent S, Ionescu-Tiba V et al (2006) Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Cancer Res 66:11649-11658 (Pubitemid 46094176)
23. Zhao F, Zhang Q, Kang C et al (2010) Suppression of matrix metal-loproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo. Med Oncol 27:774-784